Levosimendan

Known as: Levosimedan, Levosimendanum 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND This study evaluated the efficacy and safety of levosimendan, a positive inotropic drug with vasodilator effects… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2012
Review
2012
The molecular background of the Ca(2+)-sensitizing effect of levosimendan relates to its specific interaction with the Ca(2… (More)
Is this relevant?
Review
2012
Review
2012
OBJECTIVE Catecholaminergic inotropes have a place in the management of low output syndrome and decompensated heart failure but… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
CONTEXT Because acute decompensated heart failure causes substantial morbidity and mortality, there is a need for agents that at… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND The short-term infusion of levosimendan (Levo) improves hemodynamic function in patients with decompensated heart… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Levosimendan, a novel calcium sensitiser, improves myocardial contractility without causing an increase in myocardial… (More)
  • table 1
  • table 2
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVES We sought to define the therapeutic dose range of levosimendan in patients with New York Heart Association class II-IV… (More)
  • table 2
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND We determined the short-term hemodynamic and clinical effects of levosimendan, a novel calcium-sensitizing agent, in… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2000
Highly Cited
2000
AIMS Levosimendan, a novel calcium-dependent calcium sensitizer of the myocardial contractile proteins, also enhances diastolic… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
UNLABELLED We tested the hypothesis that levosimendan, a new positive inotropic drug that activates adenosine triphosphate… (More)
Is this relevant?